Sight Sciences - About the company
Sight Sciences is a public company based in Menlo Park (United States), founded in 2006 by Paul Badawi and David Badawi. It operates as a Developer of surgical systems for the treatment of ophthalmological diseases. Sight Sciences has raised $129M in funding from investors like Allegro Investment Fund, Janus Henderson Investors and KCK MedTech. The company has 48 active competitors, including 5 funded and 10 that have exited. Its top competitors include companies like Alcon, Iantrek and Haag-Streit.
Company Details
Developer of surgical systems for the treatment of ophthalmological diseases. The company offers a surgical system, which is indicated for canaloplasty to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and Meibomian Gland Dysfunction (MGD), dry eye, and blepharitis.
- Website
- sightsciences.com
- Registered Address
- Menlo Park, California
Key Metrics
Founded Year
2006
Location
Menlo Park, United States
Stage
Public
Total Funding
$129M in 10 rounds
Latest Funding Round
Investors
Ranked
2nd among 48 active competitors
Employee Count
242 as on Sep 30, 2026
Exit Details
Public
Legal entities associated with Sight Sciences
Sight Sciences is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Sight Sciences, Inc. CIN: 800625749 , United States, Active | Dec 31, 2005 | - | 209 (As on Dec 31, 2024) | - |
Sight Sciences's IPO details
Sight Sciences got listed on Jul 15, 2021.
Click here to take a look at Sight Sciences's IPO in detail
Sign up to download Sight Sciences' company profile
Sight Sciences's funding and investors
Sight Sciences has raised a total funding of $129M over 10 rounds. Its first funding round was on Sep 27, 2011. Its latest funding round was a Series E round on Dec 03, 2020 for $*****. 1 investor participated in its latest round. Sight Sciences has 9 institutional investors.
Here is the list of recent funding rounds of Sight Sciences:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 03, 2020 | 1682888 | Series E | 7139860 | 2418854 | 8267660 | 9435586 |
Dec 2020 | 5244980 | Conventional Debt | 3094657 | 4983848 | 2777231 | |
Mar 18, 2020 | 9460376 | Series E | 3618748 | 6302711 | 8750812 | 4293848 |
View details of Sight Sciences's funding rounds and investors
Sight Sciences' founders and board of directors
Founder? Claim ProfileThe founders of Sight Sciences are Paul Badawi and David Badawi.
Here are the details of Sight Sciences' key team members:
- Paul Badawi: Co-founder & CEO of Sight Sciences.
- David Badawi: Co-Founder & CTO of Sight Sciences.
View details of Sight Sciences's Founder profiles and Board Members
Sight Sciences' employee count trend
Sight Sciences has 242 employees as of Sep 26. Here is Sight Sciences's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Sight Sciences's Competitors and alternates
Top competitors of Sight Sciences include Alcon, Iantrek and Haag-Streit. Here is the list of Top 10 competitors of Sight Sciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Alcon 1945, Fort Worth (United States), Public | Developer of a wide range of eye care products | $187M | 70/100 | |
2nd | Sight Sciences 2006, Menlo Park (United States), Public | Developer of surgical systems for the treatment of ophthalmological diseases | $129M | 68/100 | |
3rd | Iantrek 2019, White Plains (United States), Series C | Developer of a minimally invasive eye surgery technology | $97.8M | 58/100 | |
4th | Haag-Streit 1858, Switzerland, Acquired | Manufacturer of ophthalmic diagnostic equipment and precision micro surgical instruments | - | - | 54/100 |
5th | Surgical equipment for anterior chamber Ophthalmic surgery | $31M | 42/100 | ||
6th | ![]() Zhitong Technology 2020, Jiaxing (China), Series A | Developer of surgical devices for ophthalmic indications | $13.7M | 35/100 | |
7th | Medicel 1996, Thal (Switzerland), Acquired | Developer of ophthalmic surgical instruments | - | - | 32/100 |
8th | X-BIOMEDICAL 2017, Wayne (United States), Seed | Revolutionizing microscopy with portable AI & VR systems for healthcare | - | - | 32/100 |
9th | Cutting Edge 2015, Montpellier (France), Funding Raised | Developer of ophthalmological products | - | 32/100 | |
10th | Epsilon Eye Care 1997, Mumbai (India), Unfunded | Manufacturer of ophthalmic precision surgical instruments | - | - | 31/100 |
Looking for more details on Sight Sciences's competitors? Click here to see the top ones
Sight Sciences's Investments and acquisitions
Sight Sciences has made no investments or acquisitions yet.
Reports related to Sight Sciences
Here is the latest report on Sight Sciences's sector:
News related to Sight Sciences
Media has covered Sight Sciences for a total of 9 events in the last 1 year, 2 of them have been about company updates.
•
Sight Sciences to Debut the OMNI Ultra® Surgical System at AAO 2026GlobeNewswire•Oct 01, 2026•Sight Sciences
•
Sight Sciences' TearCare System Receives Expanded FDA Indication for MGD TreatmentGlobeNewswire•Aug 19, 2026•Sight Sciences
•
Sight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical SystemGlobeNewswire•Aug 05, 2026•Sight Sciences
•
Sight Sciences wins $34M in Alcon patent case, ongoing royaltyInvesting•Mar 30, 2026•Sight Sciences, Alcon
•
Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire•Mar 05, 2026•Sight Sciences
•
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial HighlightsGlobeNewswire•Jan 13, 2026•Sight Sciences
•
Sight Sciences:New Publications Highlight OMNI Surgical System Effectiveness in Reducing IOPGlobeNewswire•Nov 11, 2025•Sight Sciences
•
Sight Sciences Announces Fee Schedule Establishment for TearCare ProcedureGlobeNewswire•Oct 17, 2025•Sight Sciences
•
4,374,975 Shares in Sight Sciences, Inc. $SGHT Acquired by Kck Ltd.MarketBeat•Sep 16, 2025•Kck Industries, Sight Sciences
•
Sight Sciences Announces Recognition of the TearCare System in TFOS DEWS III Global Dry Eye GuidelinesGlobeNewswire•Sep 03, 2025•Sight Sciences
Are you a Founder ?
FAQs about Sight Sciences
Explore our recently published companies
- Ks Nancy - Unfunded company
- ABEDiscovery - United States based, 2015 founded, Funding Raised company
- Caron Communications - Wethersfield based, 2025 founded, Unfunded company
- Oji - Public company
- FONEGIANT - United Kingdom based, Unfunded company
- Soft'n'Hard - Russia based, Unfunded company
